iShares 3 7 Year Treasury Bond ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? iShares 3 7 Year Treasury Bond ETF trades at $114.13 (market cap $16.82B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: iShares 3 7 Year Treasury Bond ETF is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while iShares 3 7 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares 3 7 Year Treasury Bond ETF for 45 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| IEI | RDY | |
|---|---|---|
Market Cap | $16.82B | $10.61B |
Volume | 1,654,435 | 3,738,869 |
Sector | Fixed Income | Health |
52-Week High | $120.72 | $15.38 |
52-Week Low | $113.17 | $11.38 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | — | $10.51B |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
IEI trades at $113.57 with minimal daily movement (+0.08%), showing stability amid broader bond market volatility. Technical indicators signal a bearish trend with moving averages pointing downward, though oscillators remain neutral. The stock faces pressure from rising Treasury yields and inflation concerns, with recent news highlighting bond market turbulence and higher interest rate expectations.
The outlook remains cautious as rising yields challenge fixed-income alternatives, while the company's dividend payments provide some income stability. Key risks include persistent inflation and Fed policy uncertainty. Analyst sentiment appears mixed given the challenging interest rate environment and macroeconomic headwinds affecting the broader financial sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →